Metraipolis › archive › dc_66ef29de02ed

An Insight on Ellagic Acid Formulations for the Management of Skin Diseases — Europe PMC PMID:41375091

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41375091
DOI
10.3390/molecules30234493
License (as archived)
solo-consultazione
Archived
2026-11-08T08:46:53.507Z
SHA-256 of the archived text
82db0adce9da76d9a1eb7455e2db65ff926e8375af8b2b6748c5f410daca165f
Stable URL of this page
https://metraipolis.com/documento/dc_66ef29de02ed

How to cite

An Insight on Ellagic Acid Formulations for the Management of Skin Diseases — Europe PMC PMID:41375091 — Europe PMC (en), https://europepmc.org/article/MED/41375091 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_66ef29de02ed (Metraipolis archive dc_66ef29de02ed, sha256 82db0adce9da76d9a1eb7455e2db65ff926e8375af8b2b6748c5f410daca165f)
BibTeX
@misc{dc66ef29de02ed,
  title = {An Insight on Ellagic Acid Formulations for the Management of Skin Diseases — Europe PMC PMID:41375091},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41375091},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_66ef29de02ed; sha256 82db0adce9da76d9a1eb7455e2db65ff926e8375af8b2b6748c5f410daca165f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41375091. Agents can read the archived copy with the MCP tool read_document.